Literature DB >> 18773185

Mechanisms of angiotensin II signaling on cytoskeleton of podocytes.

Hsiang-Hao Hsu1, Sigrid Hoffmann, Nicole Endlich, Ana Velic, Albrecht Schwab, Thomas Weide, Eberhard Schlatter, Hermann Pavenstädt.   

Abstract

Podocytes are significant in establishing the glomerular filtration barrier. Sustained rennin-angiotensin system (RAS) activation is crucial in the pathogenesis of podocyte injury and causes proteinuria. This study demonstrates that angiotensin II (Ang II) caused a reactive oxygen species (ROS)-dependent rearrangement of cortical F-actin and a migratory phenotype switch in cultured mouse podocytes with stable Ang II type 1 receptor (AT1R) expression. Activated small GTPase Rac-1 and phosphorylated ezrin/radixin/moesin (ERM) proteins provoked Ang II-induced F-actin cytoskeletal remodeling. This work also shows increased expression of Rac-1 and phosphorylated ERM proteins in cultured podocytes, and in glomeruli of podocyte-specific AT1R transgenic rats (Neph-hAT1 TGRs). The free radical scavenger DMTU eliminated Ang II-induced cell migration, ERM protein phosphorylation and cortical F-actin remodeling, indicating that ROS mediates the influence of Rac-1 on podocyte AT1R signaling. Heparin, a potent G-coupled protein kinase 2 inhibitor, was found to abolish ERM protein phosphorylation and cortical F-actin ring formation in Ang II-treated podocytes, indicating that phosphorylated ERM proteins are the cytoskeletal effector in AT1R signaling. Moreover, Ang II stimulation triggered down-regulation of alpha actinin-4 and reduced focal adhesion expression in podocytes. Signaling inhibitor assay of Ang II-treated podocytes reveals that Rac-1, RhoA, and F-actin reorganization were involved in expressional regulation of alpha actinin-4 in AT1R signaling. With persistent RAS activation, the Ang II-induced phenotype shifts from being dynamically stable to adaptively migratory, which may eventually exhaust podocytes with a high actin cytoskeletal turnover, causing podocyte depletion and focal segmental glomerulosclerosis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18773185     DOI: 10.1007/s00109-008-0399-y

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  40 in total

Review 1.  ERM proteins and merlin: integrators at the cell cortex.

Authors:  Anthony Bretscher; Kevin Edwards; Richard G Fehon
Journal:  Nat Rev Mol Cell Biol       Date:  2002-08       Impact factor: 94.444

2.  Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis.

Authors:  J M Kaplan; S H Kim; K N North; H Rennke; L A Correia; H Q Tong; B J Mathis; J C Rodríguez-Pérez; P G Allen; A H Beggs; M R Pollak
Journal:  Nat Genet       Date:  2000-03       Impact factor: 38.330

Review 3.  Molecular biology of angiotensin receptors and their role in human cardiovascular disease.

Authors:  V Regitz-Zagrosek; M Neuss; J Holzmeister; C Warnecke; E Fleck
Journal:  J Mol Med (Berl)       Date:  1996-05       Impact factor: 4.599

4.  Angiotensin II increases the intracellular calcium activity in podocytes of the intact glomerulus.

Authors:  R Nitschke; A Henger; S Ricken; J Gloy; V Müller; R Greger; H Pavenstädt
Journal:  Kidney Int       Date:  2000-01       Impact factor: 10.612

5.  Permselective dysfunction of podocyte-podocyte contact upon angiotensin II unravels the molecular target for renoprotective intervention.

Authors:  Daniela Macconi; Mauro Abbate; Marina Morigi; Stefania Angioletti; Marilena Mister; Simona Buelli; Maria Bonomelli; Peter Mundel; Karlhans Endlich; Andrea Remuzzi; Giuseppe Remuzzi
Journal:  Am J Pathol       Date:  2006-04       Impact factor: 4.307

6.  Overexpression of the human angiotensin II type 1 receptor in the rat heart augments load induced cardiac hypertrophy.

Authors:  S Hoffmann; T Krause; P P van Geel; R Willenbrock; I Pagel; Y M Pinto; H Buikema; W H van Gilst; C Lindschau; M Paul; T Inagami; D Ganten; H Urata
Journal:  J Mol Med (Berl)       Date:  2001-10       Impact factor: 4.599

7.  Endogenous ARF6 interacts with Rac1 upon angiotensin II stimulation to regulate membrane ruffling and cell migration.

Authors:  Mathieu Cotton; Pierre-Luc Boulay; Tanguy Houndolo; Nicolas Vitale; Julie A Pitcher; Audrey Claing
Journal:  Mol Biol Cell       Date:  2006-11-22       Impact factor: 4.138

8.  Requirement of Rac1 in the development of cardiac hypertrophy.

Authors:  Minoru Satoh; Hisakazu Ogita; Kyosuke Takeshita; Yasushi Mukai; David J Kwiatkowski; James K Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-01       Impact factor: 11.205

9.  Mice deficient in alpha-actinin-4 have severe glomerular disease.

Authors:  Claudine H Kos; Tu Cam Le; Sumita Sinha; Joel M Henderson; Sung Han Kim; Hikaru Sugimoto; Raghu Kalluri; Robert E Gerszten; Martin R Pollak
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

10.  Functional expression of the renin-angiotensin system in human podocytes.

Authors:  Max C Liebau; D Lang; J Böhm; N Endlich; Martin J Bek; Ian Witherden; Peter W Mathieson; Moin A Saleem; Hermann Pavenstädt; Karl-Georg Fischer
Journal:  Am J Physiol Renal Physiol       Date:  2005-09-27
View more
  67 in total

1.  Kindlin-2 Association with Rho GDP-Dissociation Inhibitor α Suppresses Rac1 Activation and Podocyte Injury.

Authors:  Ying Sun; Chen Guo; Ping Ma; Yumei Lai; Fan Yang; Jun Cai; Zhehao Cheng; Kuo Zhang; Zhongzhen Liu; Yeteng Tian; Yue Sheng; Ruijun Tian; Yi Deng; Guozhi Xiao; Chuanyue Wu
Journal:  J Am Soc Nephrol       Date:  2017-08-03       Impact factor: 10.121

2.  Marker expression, behaviors, and responses vary in different lines of conditionally immortalized cultured podocytes.

Authors:  Seetharamaiah Chittiprol; Phylip Chen; Danica Petrovic-Djergovic; Tad Eichler; Richard F Ransom
Journal:  Am J Physiol Renal Physiol       Date:  2011-06-01

3.  Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease.

Authors:  Akihiro Fukuda; Larysa T Wickman; Madhusudan P Venkatareddy; Yuji Sato; Mahboob A Chowdhury; Su Q Wang; Kerby A Shedden; Robert C Dysko; Jocelyn E Wiggins; Roger C Wiggins
Journal:  Kidney Int       Date:  2011-09-21       Impact factor: 10.612

4.  Nef interaction with actin compromises human podocyte actin cytoskeletal integrity.

Authors:  Raymond Tan; Hitesh Patni; Pranai Tandon; Liming Luan; Bipin Sharma; Divya Salhan; Moin A Saleem; Peter W Mathieson; Ashwani Malhotra; Mohammad Husain; Poornima Upadhya; Pravin C Singhal
Journal:  Exp Mol Pathol       Date:  2012-06-18       Impact factor: 3.362

5.  Epigallocatechin gallate inhibits angiotensin II-induced endothelial barrier dysfunction via inhibition of the p38 MAPK/HSP27 pathway.

Authors:  Dan Yang; Jing Liu; Cui Tian; Yong Zeng; Yue-hong Zheng; Quan Fang; Hui-hua Li
Journal:  Acta Pharmacol Sin       Date:  2010-07-19       Impact factor: 6.150

6.  Cyclic AMP prevents decrease of phosphorylated ezrin/radixin/moesin and chloride intracellular channel 5 expressions in injured podocytes.

Authors:  Hua Tao; Xiaoying Li; Kai Wei; Kewei Xie; Zhaohui Ni; Leyi Gu
Journal:  Clin Exp Nephrol       Date:  2015-03-01       Impact factor: 2.801

7.  Antagonistic regulation of actin dynamics and cell motility by TRPC5 and TRPC6 channels.

Authors:  Dequan Tian; Sarah M P Jacobo; David Billing; Anete Rozkalne; Steven D Gage; Theodora Anagnostou; Hermann Pavenstädt; Hermann Pavenstaedt; Hsiang-Hao Hsu; Johannes Schlondorff; Arnolt Ramos; Anna Greka
Journal:  Sci Signal       Date:  2010-10-26       Impact factor: 8.192

Review 8.  Mitochondrial energetics and therapeutics.

Authors:  Douglas C Wallace; Weiwei Fan; Vincent Procaccio
Journal:  Annu Rev Pathol       Date:  2010       Impact factor: 23.472

9.  A small-molecule inhibitor of TRPC5 ion channels suppresses progressive kidney disease in animal models.

Authors:  Yiming Zhou; Philip Castonguay; Eriene-Heidi Sidhom; Abbe R Clark; Moran Dvela-Levitt; Sookyung Kim; Jonas Sieber; Nicolas Wieder; Ji Yong Jung; Svetlana Andreeva; Jana Reichardt; Frank Dubois; Sigrid C Hoffmann; John M Basgen; Mónica S Montesinos; Astrid Weins; Ashley C Johnson; Eric S Lander; Michael R Garrett; Corey R Hopkins; Anna Greka
Journal:  Science       Date:  2017-12-08       Impact factor: 47.728

Review 10.  Molecular genetic analysis of podocyte genes in focal segmental glomerulosclerosis--a review.

Authors:  M M Löwik; P J Groenen; E N Levtchenko; L A Monnens; L P van den Heuvel
Journal:  Eur J Pediatr       Date:  2009-06-27       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.